You need to sign in or sign up before continuing.
Scan barcode
398 pages • missing pub info (editions)
ISBN/UID: 9781498750394
Format: Hardcover
Language: English
Publisher: CRC Press
Publication date: 25 July 2018
Description
Summary: The focus of this book is on how the U.S. FDA will approve biosimilar drugs, as learned from recent approvals by the FDA. Understanding the limitations of the statutory limits and non-inferiority testing are presented as tools to obviate...
Community Reviews
Content Warnings
398 pages • missing pub info (editions)
ISBN/UID: 9781498750394
Format: Hardcover
Language: English
Publisher: CRC Press
Publication date: 25 July 2018
Description
Summary: The focus of this book is on how the U.S. FDA will approve biosimilar drugs, as learned from recent approvals by the FDA. Understanding the limitations of the statutory limits and non-inferiority testing are presented as tools to obviate...
Community Reviews
Content Warnings